Cite
HARVARD Citation
Makiyama, A. et al. (n.d.). 167PPrognostic impact of the C-reactive protein/albumin ratio in advanced pancreatic cancer treated with GEM plus nab-PTX or FOLFIRINOX: Based on the results of a multicenter retrospective study (the NAPOLEON study). Annals of oncology. p. . [Online].